CO(2) laser surgery in the treatment of glottic cancer
- PMID: 15898101
- DOI: 10.1002/hed.20135
CO(2) laser surgery in the treatment of glottic cancer
Abstract
Background: The aim of the study was to assess the effectiveness of CO(2) laser endoscopic surgery in the treatment of glottic carcinoma limited to the true vocal cords or involving the adjacent regions.
Methods: Seven hundred nineteen patients (687 men and 32 women; mean age, 60.4 years; range, 33-86 years) with glottic carcinoma (432 T1N0M0, 236 T2N0M0, 51 T3N0M0) underwent CO(2) laser surgery (mean follow-up, 5 years; range, 2-17 years). Statistical comparison was carried out with Wilcoxon test, considering p < .05 the minimum significance value.
Results: Overall actuarial survival, adjusted actuarial survival, and percentage of patients with no evidence of disease at 5 years were 85%, 97%, and 85%, respectively, in patients with T1a disease; 84%, 96%, and 83% in those with T1b disease; 77%, 86%, and 61% in those with T2 unilateral tumors; 77%, 88%, and 55% in those with T2 bilateral tumors; and 64%, 72%, and 60% in those with T3 disease. The statistical analysis showed the following: significant differences in the comparison of T1 versus T2 and T2 versus T3 tumors (p < .01), with the exception of no evidence of disease in the comparison of T2 versus T3 (p > .05); and no significant differences in the comparison of unilateral and bilateral tumors (p > .05). Actuarial local control, actuarial nodal control, and actuarial distant metastasis control at 5 years were 85%, 98%, and 99%, respectively, in patients with T1 disease; and 66%, 82%, and 91% in patients with T2 disease; and 66%, 83%, and 95% in patients with T3 disease. The laryngeal preservation rate was 97.3% in the T1 group, 82.5% in the T2 group, and 80.5% in T3 group.
Conclusions: CO(2) laser endoscopic surgery is effective in the treatment of glottic carcinoma not infiltrating the cartilaginous skeleton; the results achieved are competitive with those of open conservative operations, if we take into account the possibilities afforded by salvage surgery and the rate of laryngeal preservation achieved in the study patients.
Comment in
-
CO2 laser surgery in the treatment of glottic cancer.Head Neck. 2005 Aug;27(8):733. doi: 10.1002/hed.20266. Head Neck. 2005. PMID: 15986477 No abstract available.
Similar articles
-
CO2 laser treatment of supraglottic cancer.Head Neck. 2004 May;26(5):442-6. doi: 10.1002/hed.10395. Head Neck. 2004. PMID: 15122661
-
Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.Head Neck. 2009 Jun;31(6):759-64. doi: 10.1002/hed.21027. Head Neck. 2009. PMID: 19260127
-
Oncological outcome after CO2 laser cordectomy for early-stage glottic carcinoma.Acta Otorhinolaryngol Ital. 2005 Apr;25(2):86-93. Acta Otorhinolaryngol Ital. 2005. PMID: 16116830 Free PMC article.
-
Partial laryngectomy after irradiation failure.Otolaryngol Head Neck Surg. 2003 Feb;128(2):200-9. doi: 10.1067/mhn.2003.63. Otolaryngol Head Neck Surg. 2003. PMID: 12601315 Review.
-
Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.Am J Otolaryngol. 2001 Jan-Feb;22(1):43-54. doi: 10.1053/ajot.2001.20679. Am J Otolaryngol. 2001. PMID: 11172214 Review.
Cited by
-
Vocal Fold Cancer Transoral Laser Microsurgery Following European Laryngological Society Laser Cordectomy Classification.Front Oncol. 2018 Jun 22;8:231. doi: 10.3389/fonc.2018.00231. eCollection 2018. Front Oncol. 2018. PMID: 29988339 Free PMC article.
-
Comparative ex vivo Investigations on the Cutting Quality of the CO2 Laser and the Diode Pumped Er:YAG Laser.Front Surg. 2021 Dec 14;8:764450. doi: 10.3389/fsurg.2021.764450. eCollection 2021. Front Surg. 2021. PMID: 34970590 Free PMC article.
-
Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery.Eur Arch Otorhinolaryngol. 2015 Aug;272(8):1983-90. doi: 10.1007/s00405-015-3611-z. Epub 2015 Mar 29. Eur Arch Otorhinolaryngol. 2015. PMID: 25821031
-
Clinical, Histological and Immunohistochemical Evaluation of Larynx Cancer.Curr Health Sci J. 2017 Oct-Dec;43(4):367-375. doi: 10.12865/CHSJ.43.04.14. Epub 2017 Dec 28. Curr Health Sci J. 2017. PMID: 30595905 Free PMC article.
-
The Oncologic Value of Transoral Resection in Early-Stage Laryngeal Squamous Cell Carcinoma of the Glottis: A Retrospective Study.Cureus. 2024 Sep 23;16(9):e69975. doi: 10.7759/cureus.69975. eCollection 2024 Sep. Cureus. 2024. PMID: 39449894 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources